Crystal structure of human alpha-n-acetylglucosaminidase
AssigneeShire Human Genetic Therapies, Inc.
InventorsMuthuraman Meiyappan, Michael F. Concino, Angela W. Norton
Life of this patent
Estimating the term…
Loading patent…
AssigneeShire Human Genetic Therapies, Inc.
InventorsMuthuraman Meiyappan, Michael F. Concino, Angela W. Norton
Estimating the term…
The present invention provides the three-dimensional structure of human α-N-acetylglucosaminidase (NAGLU) protein. This crystallographic information is useful in the identification and development of novel binding compounds of NAGLU, NAGLU mutants, for example, those associated with Sanfilippo syndrome type B (mucopolysaccharidosis III B (MPS III-B)), and other NAGLU family members (family 89 α-N-acetylglucosaminidase) which may modulate the activity and/or stability of mutated NAGLU. Such compounds may be useful for the treatment of Sanfilippo syndrome type B (mucopolysaccharidosis III B (MPS III-B)).
1-73. (canceled)
A method of obtaining a purified recombinant NAGLU polypeptide with an altered glycosylation pattern compared to native NAGLU, the method comprising:
(canceled)
83-84. (canceled)
87-89. (canceled)
91-93. (canceled)
96-102. (canceled)
106-110. (canceled)
(canceled)
(canceled)
116-133. (canceled)
Dependencies are inferred from the claim text.